icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
r2Rwn9kR5U2JvLc8
Listen
